Scholarly Index
Pei Lin
The University of Texas MD Anderson Cancer Center; 9,553 total citations; 315 total publications; best world rank #477
The University of Texas MD Anderson Cancer Center
9,553Total citations
315Total publications
52H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Chronic Lymphocytic Leukemia Research | Lifetime | 785 | US 363 | 98.10 |
| Lymphoma Diagnosis and Treatment | Lifetime | 855 | US 372 | 98.05 |
| Acute Myeloid Leukemia Research | Lifetime | 863 | US 384 | 97.71 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 673 | US 299 | 97.13 |
| Multiple Myeloma Research and Treatments | Lifetime | 778 | US 347 | 96.32 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 629 | US 261 | 95.76 |
| Viral-associated cancers and disorders | Lifetime | 930 | US 387 | 95.78 |
| CNS Lymphoma Diagnosis and Treatment | Lifetime | 650 | US 273 | 93.03 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 752 | US 340 | 90.25 |
| Protein Degradation and Inhibitors | 2021-2025 | 936 | US 392 | 84.80 |
| Viral-associated cancers and disorders | 2021-2025 | 964 | US 341 | 77.07 |
| Chemokine receptors and signaling | 2021-2025 | 477 | US 87 | 63.17 |